REG - Tristel PLC - CFO succession planning

TristelAnnouncement

15/05/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250515:nRSO7165Ia&default-theme=true

RNS Number : 7165I  Tristel PLC  15 May 2025

TRISTEL plc

("Tristel" or the "Company" or the "Group")

 

CFO succession planning

 

Tristel plc (AIM: TSTL), the manufacturer of infection prevention products,
announces that Liz Dixon, Chief Financial Officer ("CFO"), has confirmed to
the Board her intention to retire from the business on 30 June 2025.

 

A process to appoint a new CFO is well underway and the Board has been pleased
with the quality of candidates showing an interest in the position. A further
announcement will be made in due course.

 

Bruno Holthof, Chair of the Tristel Board, commented: "On behalf of the
Company I would like to offer my thanks to Liz for her contribution to the
business over the years. Liz has been involved with Tristel since July 2007
when she joined as Group Chief Accountant, before becoming Finance Director of
our main trading subsidiary in August 2009, and ultimately joining the Board
in June 2010. She played a critical role in securing market access to North
America and has positioned Tristel very well for continued profitable growth."

 

Matt Sassone, Chief Executive Officer of Tristel, commented: "Since Liz joined
Tristel, the company has grown considerably, and Liz has played a pivotal role
in that success. In addition to supporting the operational side of the
business, she has been instrumental in driving our commercial performance and
built a robust, capable finance team-ensuring we are well-positioned for the
continued expansion we anticipate in the years ahead.

 

"It has been a pleasure to work with Liz over the last nine months, and I am
grateful that due to her stewardship I have joined a business with a very
strong financial position, and well-funded to deliver further organic
commercial growth."

 

Liz Dixon, Chief Financial Officer of Tristel, commented: "Whilst I am very
sad to be leaving Tristel after nearly 18 years, I do so happy in the
knowledge that the business is well placed both financially and commercially
for its next stage of growth under the leadership of Matt and the senior team.

 

"It has been a great pleasure to have been part of an amazing UK success
story, and to see Tristel establish a leading position in the global infection
prevention world. I wish the incredible Tristel team the very best and am
confident that they will continue to deliver to our shareholders."

 

The information communicated in this announcement is inside information for
the purposes of Article 7 of Regulation 596/2014.

 

 

For further information please contact:

 

 Tristel plc                                                                Via Walbrook PR
 Matt Sassone, Chief Executive Officer                                      www.investors.tristel.com (http://www.investors.tristel.com/)
 Liz Dixon, Chief Financial Officer

 Walbrook PR Ltd                                                            Tel: 020 7933 8780 or tristel@walbrookpr.com
 Paul McManus / Lianne Applegarth / Alice Woodings    Mob: 07980 541 893/ 07584 391 303/ 07407 804 654

 Cavendish Capital Markets Ltd                                              Tel: 020 7220 0500
 Geoff Nash / Trisyia Jamaludin (Corporate Finance)
 Sunila de Silva (Corporate Broking) / Louise Talbot (Sales)

 

About Tristel plc

Tristel plc is a global infection prevention company focussed on the
manufacture and supply of products using its unique proprietary chlorine
dioxide (ClO(2)) chemistry. The Company is a market leader in manual
decontamination of medical devices, supplying hospitals under the Tristel
(https://tristel.com/) brand, and under the Cache
(https://thecachecollection.com/) brand provides products for sporicidal
surface disinfection, a more sustainable alternative to commonly used
pre-wetted plastic wipes.

 

Tristel's head office and manufacturing facility is located in Snailwell, near
Cambridge, and operates globally employing approximately 270 people across 16
subsidiaries selling into 40+ countries. The Company targets annual revenue
growth of between 10% and 15% and an EBITDA margin of at least 25% and the
business is profitable, with no debt and has a progressive dividend policy.

 

The Company has been listed on the London Stock Exchange's AIM market since
2005 (AIM: TSTL).

 

For more information about Tristel's product range please visit:
https://tristel.com (https://tristel.com)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAFLFFREIISLIE